Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues

Virology

Volumn 247, Issue 2, 1998, Pages 152-159

  Takasaka, Noriko ^a   Tajima, Masako ^b   Okinaga, Kota ^b   Satoh, Yukio ^a   Hoshikawa, Yoshiko ^a   Katsumoto, Tetsuo ^a   Kurata, Takeshi ^c   Sairenji, Takeshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EPITHELIUM; VIRUS CHARACTERIZATION; VIRUS INFECTIVITY;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032145665     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9231     Document Type: Article

References (45)

1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
2. Daibata M., Humphreys R. E., Sairenji T. Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene productZEBRA. Virology. 188:1992;916-920.
3. Dambaugh T. R., Kieff E. Identification and nucleotide sequences to two similar tandem direct repeats in Epstein-Barr virus DNA. J. Virol. 44:1982;823-833.
4. Fukayama M., Hayashi Y., Iwasaki Y., Chong J., Ooba T., Takizawa T., Koike M., Mizutani S., Miyaki M., Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 71:1994;73-81.
5. Glaser R., Zhang H. Y., Yao K. T., Zhu H. C., Wang F. X., Li G. Y., Wen D. S., Li Y. P. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc. Natl. Acad. Sci. USA. 86:1989;9524-9528.
6. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1985;1564-1571.
7. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R. Jr., Grace J. T. Jr. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1:1967;1045-1051.
8. Hitt M. M., Allday M. J., Hara T., Karran L., Jones M. D., Busson P., Tursz T., Ernberg I., Griffin B. E. EBV gene expression in an NPC-related tumour. EMBO J. 8:1989;2639-2651.
9. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA. 91:1994;9131-9135.
10. Katsumoto T., Hirano A., Kurimura T., Takagi A. In situ. J. Gen. Virol. 52:1981;267-278.
11. Klein G., Giovanella B., Westman A., Stehlin J. S., Mumford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma: Receptor characteristics, EBV infectibility and permanent conversion into EBV-positive sublines byin vitro. Intervirology. 5:1975;319-334.
12. Knox P. G., Li Q. X., Rickinson A. B., Young L. S. In vitro. Virology. 215:1996;40-50.
13. Kunimoto M., Tamura S., Tabata T., Yoshie O. One-step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 virus in Japan. J. Gen. Virol. 73:1992;455-461.
14. Li Q. X., Young L. S., Niedobitek G., Dawson C. W., Birkenbach M., Wang F., Rickinson A. B. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 356:1992;347-350.
15. Luka J., Kallin B., Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 94:1979;228-231.
16. Miller G. The Epstein-Barr virus. Virology. 1990;Raven Press, New York. p. 1921-1957.
17. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
18. Min K. W., Holmquist S., Peiper S. C., O'Leary T. J. Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach: Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am. J. Clin. Pathol. 96:1991;219-227.
19. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333:1995;693-698.
20. Pulvertaft R. J. V. A study of malignant tumors in Nigeria by short term tissue culture. J. Clin. Pathol. 18:1965;261-273.
21. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 47:1986;883-889.
22. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer. 11:1973;499-520.
23. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Fields' Virology. 1996;2397-2445 Raven Press, New York.
24. Sairenji T., Hinuma Y. Assay of Epstein-Barr virus by immunofluorescence. Gann. 64:1973;633-636.
25. Sairenji T., Hinuma Y. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int. J. Cancer. 26:1980;337-342.
26. Sairenji T., Reisert P. S., Spiro R. C., Connolly T., Humphreys R. E. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. J. Exp. Med. 161:1985;1097-1111.
27. Sato H., Takimoto T., Pagano J. S., Raab-Traub N. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma. J. Virol. 62:1988;3288-3294.
28. Sato H., Takimoto T., Tanaka S., Tanaka J., Raab-Traub N. Concatameric replication of Epstein-Barr virus: Structure of the termini in virus-producer and newly transformed cell lines. J. Virol. 6 4:1990;5295-5300.
29. Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L. M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration: Lymphoepithelioma-like carcinoma. Am. J. Pathol. 139:1991;469-474.
30. Shibata D., Weiss L. M. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 140:1992;769-774.
31. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1984;1225-1230.
32. Sunita Z., Elizabeth H.-G., Shannon K. Epstein-Barr viral latency is disrupted by the immediate-early RLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
33. Tajima M., Komuro M., Okinaga K. Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn. J. Cancer Res. 89:1998;262-268.
34. Takada K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:1989;445-449.
35. Takasaka N., Satoh Y., Hosikawa Y., Osaki M., Ito H., Chen J.-Y., Sairenji T. Inprovement in the detection of Epstein-Barr virus DNA on paraffin-embedded gastric carcinoma tissues: Treatment of extracted cellular DNA with a restriction enzyme prior to polymerase chain reaction. Yonago Acta Med. 39:1996;171-176.
36. Takimoto T., Ogura H., Sato H., Umeda R., Hatano M. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J. Natl. Cancer. Inst. 74:1985;57-60.
37. Telenti A., T. F. Smith J. L., Keating M. R., Krom. R. A. F., Wiesner R. H. Epstein-Barr virus and persistent graft dysfunction and liver transplantation. Hepatology. 14:1991;282-286.
38. Thorley-Lawson D. A., Geilinger K. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc. Natl. Acad. Sci. USA. 77:1980;5307-5311.
39. Tokunaga M., Land C. E., Uemura Y., Tokudome T., Tanaka S., Sato E. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 143:1993a;1250-1254.
40. Tokunaga M., Uemura Y., Tokudome T., Ishidate T., Masuda H., Okazaki E., Kaneko K., Naoe S., Ito M., Okamura A. Epstein-Barr virus related gastric cancer in Japan: A molecular patho-epidemiological study. Acta Pathol. Jpn. 43:1993b;574-581.
41. Yao K. T., Zhang H. Y., Zhu H. C., Wang F. X., Li G. Y., Wen D. S., Li Y. P., Tsai C. H., Glaser R. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int. J. Cancer. 45:1990;83-89.
42. Yoshiyama H., Imai S., Shimizu N., Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21. J. Virol. 71:1997;5688-5691.
43. Zalani S., Holley Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
44. Zhang H. Y., Yao K., Zhu H. C., Glaser R. Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Int. J. Cancer. 46:1990;944-949.
45. zur Hausen H., O'Neill F. J., Freese U. K., Hecker E. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 272:1978;373-375.